I2P

NPS Media Release – Australian Prescriber

Get the latest article on Hepatitis C as well as information on Ceritinib, a new drug for the treatment of non-small cell lung cancer..
  Australian Prescriber NPS MedicineWise  
INDEPENDENT. NOT-FOR-PROFIT. EVIDENCE BASED.
EARLY RELEASE
7 MARCH 2017
Hep C
ARTICLE
What are the essential steps in treating hepatitis C in primary care and when should you refer patients to a specialist or liver clinic?
Lungs
NEW DRUG
Find out about the efficacy and safety of ceritinib in patients with non-small cell lung cancer.
AP logo NPS-negative
Facebook Twitter LinkedIn YouTube Google+ Instagram
© 2016 NPS MedicineWise | ABN: 61 082 034 393
Independent. Not-for-profit. Evidence based. NPS MedicineWise enables better decisions about medicines and medical tests. We are funded by the Australian Government Department of Health.
Head Office: Level 7, 418A Elizabeth St, Surry Hills NSW 2010

Leave a Reply

Your email address will not be published. Required fields are marked *